PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30940655-9	2019	Moreover, RET and Src co-high expression was an independent unfavorable prognosis factor in melanoma patients with or without ICB through inhibiting the antitumor immune response.	indole-2-carboxylic acid	126-129	SRC proto-oncogene, non-receptor tyrosine kinase	Homo sapiens	18-21	
30940655-10	2019	CONCLUSIONS: Our data unveiled a new mechanism of alleviating IFNgamma-induced PD-L1 and IDO1 expression and provided a rationale to explore a novel combination of ICB with regorafenib clinically, especially in melanoma with RET/Src axis activation.	indole-2-carboxylic acid	164-167	SRC proto-oncogene, non-receptor tyrosine kinase	Homo sapiens	229-232